Anna is a half German half Italian scientist who grew up in a small town near Vienna, Austria. She is working in the field of cancer research at the University of Zürich. Currently she is facing a new challenge in her life by becoming a mom in June 2018. Anna has lived in Italy, Austria, England, Sweden and Switzerland and loves to travel the world and experience new cultures.
Anna's latest articles
InDOOR SMOKING: A SAD austrian story
12.01.2019
In 2017, the newly elected Austrian government decided to reverse a previously passed law to completely ban indoor smoking in bars and restaurants. The Austrian public reacted with big protests and petitions – all without success. The motives of the Austrian politicians are very questionable and raise serious questions about their sense of responsibility towards citizens.
Older articles
10.04.2018 – The number of breastfed babies is decreasing worldwide. General acceptance of public breastfeeding might be playing a big role in the decision of mothers not to breastfeed. The sexualisation of breasts and associated feelings of shame and judgement are leading to an unpreventable circle of events. This article provides insight on different cultural views of breastfeeding babies in public.
While travelling through India I came across a social class called “untouchables”. Being the lowest possible class of India’s society, considered outside of the traditional caste system, untouchables are facing widespread problems. Even though several measures have been taken by the government since the ’50s, members of this caste still face discrimination and segregation up until today.
Scientific publications
10.2017 – Stelling et al., “The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma”, Blood. LINK
09.2017 – Hashwah et al., “Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth”, PNAS. LINK
05.2016 – Veenstra et al., “Met and its ligand HGF are associated with clinical outcome in breast cancer”, Oncotarget. LINK